Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today we highlight:
- a blog post reviewing a recent Federal Circuit opinion and arguing a “defendant who is temporarily excluded from the market on the basis of a patent that turns out, ex post, to have been either invalid or not infringed (or otherwise unenforceable)” should be “compensated for the interim losses it suffers”;
- an article suggesting that “[s]atisfying the written description and enablement requirements has emerged as a significant challenge in patenting [antibody-drug conjugates] inventions in the U.S.”;
- an article by Former Federal Circuit Judge Kathleen O’Malley “reflecting not only on what the Founders rejected, but on what they tried to build”; and
- an article highlighting that “President Donald Trump . . . threatened a 100% tax on imports from any country that imposes a tax on digital services from United States companies.”
